These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 30231905

  • 1. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
    Winkler MS, Nierhaus A, Rösler G, Lezius S, Harlandt O, Schwedhelm E, Böger RH, Kluge S.
    Crit Care; 2018 Sep 19; 22(1):216. PubMed ID: 30231905
    [Abstract] [Full Text] [Related]

  • 2. Markers of nitric oxide are associated with sepsis severity: an observational study.
    Winkler MS, Kluge S, Holzmann M, Moritz E, Robbe L, Bauer A, Zahrte C, Priefler M, Schwedhelm E, Böger RH, Goetz AE, Nierhaus A, Zoellner C.
    Crit Care; 2017 Jul 15; 21(1):189. PubMed ID: 28709458
    [Abstract] [Full Text] [Related]

  • 3. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.
    Minerva Anestesiol; 2010 May 15; 76(5):325-33. PubMed ID: 20395894
    [Abstract] [Full Text] [Related]

  • 4. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Kulkarni P, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Respir Res; 2017 Jan 23; 18(1):25. PubMed ID: 28114935
    [Abstract] [Full Text] [Related]

  • 5. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug 23; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 6. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Lung; 2017 Dec 23; 195(6):717-727. PubMed ID: 28852826
    [Abstract] [Full Text] [Related]

  • 7. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
    Mortensen KM, Itenov TS, Haase N, Müller RB, Ostrowski SR, Johansson PI, Olsen NV, Perner A, Søe-Jensen P, Bestle MH.
    Shock; 2016 Oct 23; 46(4):365-72. PubMed ID: 27206279
    [Abstract] [Full Text] [Related]

  • 8. Asymmetric dimethylarginine levels in thyroid diseases.
    Arikan E, Karadag CH, Guldiken S.
    J Endocrinol Invest; 2007 Mar 23; 30(3):186-91. PubMed ID: 17505150
    [Abstract] [Full Text] [Related]

  • 9. A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients.
    Hannemann J, Zink A, Mileva Y, Balfanz P, Dahl E, Volland S, Illig T, Schwedhelm E, Kurth F, Stege A, Aepfelbacher M, Hoffmann A, Böger R.
    Sci Rep; 2024 Jul 08; 14(1):15739. PubMed ID: 38977837
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM, Wang Z, Wu Y, Wilson Tang WH, Hazen SL, Wang S, Elaine Husni M.
    Arthritis Res Ther; 2018 Jun 08; 20(1):123. PubMed ID: 29884228
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of L-Arginine and Endogenous Dimethylarginines in Survivor Septic Patients - A Pilot Study.
    Németh B, Kiss I, Péter I, Ajtay Z, Németh Á, Márk L, Csorba A, Kőszegi T, Mühl D, Kustán P.
    In Vivo; 2018 Jun 08; 30(5):663-9. PubMed ID: 27566088
    [Abstract] [Full Text] [Related]

  • 12. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
    Paroni R, Barassi A, Ciociola F, Dozio E, Finati E, Fermo I, Ghilardi F, Colpi GM, Corsi MM, Melzi d'Eril GV.
    Int J Androl; 2012 Oct 08; 35(5):660-7. PubMed ID: 22519580
    [Abstract] [Full Text] [Related]

  • 13. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
    Javadiyan S, Burdon KP, Whiting MJ, Abhary S, Straga T, Hewitt AW, Mills RA, Craig JE.
    Invest Ophthalmol Vis Sci; 2012 Apr 18; 53(4):1923-7. PubMed ID: 22395885
    [Abstract] [Full Text] [Related]

  • 14. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H, Puustjärvi T, Kontkanen M, Valtonen P, Teräsvirta M, Uusitalo H.
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb 18; 245(2):204-9. PubMed ID: 17024436
    [Abstract] [Full Text] [Related]

  • 15. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M, Teerlink T.
    Metabolism; 2013 Oct 18; 62(10):1455-61. PubMed ID: 23890667
    [Abstract] [Full Text] [Related]

  • 16. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S, Komáromy H, Kamson DO, Kovács N, Perlaki G, Orsi G, Molnár T, Illes Z, Nagy L, Kéki S, Deli G, Bosnyák E, Trauninger A, Pfund Z.
    Cephalalgia; 2017 May 18; 37(6):571-580. PubMed ID: 27206959
    [Abstract] [Full Text] [Related]

  • 17. Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
    Atzler D, Schwedhelm E, Nauck M, Ittermann T, Böger RH, Friedrich N.
    Clin Chem Lab Med; 2014 Dec 18; 52(12):1835-42. PubMed ID: 24945429
    [Abstract] [Full Text] [Related]

  • 18. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
    Gamil S, Erdmann J, Schwedhelm E, Bakheit KH, Abdalrahman IBB, Mohamed AO.
    Kidney Blood Press Res; 2020 Dec 18; 45(5):727-736. PubMed ID: 32814314
    [Abstract] [Full Text] [Related]

  • 19. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C.
    Atherosclerosis; 2009 Dec 18; 207(2):541-5. PubMed ID: 19501358
    [Abstract] [Full Text] [Related]

  • 20. Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study.
    Mortensen KM, Itenov TS, Stensballe J, Hillig T, Jensen CAJ, Schønemann-Lund M, Bestle MH.
    Ann Intensive Care; 2024 Aug 27; 14(1):133. PubMed ID: 39190083
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.